opc 21268 has been researched along with metallothionein in 1 studies
Studies (opc 21268) | Trials (opc 21268) | Recent Studies (post-2010) (opc 21268) | Studies (metallothionein) | Trials (metallothionein) | Recent Studies (post-2010) (metallothionein) |
---|---|---|---|---|---|
133 | 3 | 6 | 9,390 | 41 | 2,223 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, CP; Jin, QH; Kannan, H; Kato, K; Oiso, Y; Qiu, DL; Yu, NS | 1 |
1 other study(ies) available for opc 21268 and metallothionein
Article | Year |
---|---|
Enhanced cardiovascular alteration and Fos expression induced by central salt loading in a conscious rat transgenic for the metallothionein-vasopressin fusion gene.
Topics: Animals; Animals, Genetically Modified; Antidiuretic Hormone Receptor Antagonists; Arginine; Brain; Cardiovascular System; Consciousness; Immunohistochemistry; Injections, Intraventricular; Male; Metallothionein; Oncogene Proteins v-fos; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Recombinant Fusion Proteins; Saline Solution, Hypertonic; Sodium Chloride; Vasopressins | 2005 |